CALIFORNIA ST 4%

DENVER COLO CITY & CNTY BRD WTR COMMRS WTR REV 5%

HOUSTON TEX UTIL SYS REV 5%

MARYLAND ST 5%

NEW JERSEY ST 5%

NEW JERSEY ST EDL FACS AUTH REV 2%

NEW YORK N Y CITY TRANSITIONAL FIN AUTH REV 4%

NEW YORK ST URBAN DEV CORP ST SALES TAX REV 5%

TRIBOROUGH BRDG & TUNL AUTH N Y PAYROLL MOBILITY TAX 2%

The fund normally invests at least 80% of its total assets in fixed income securities that comprise the index. The index is comprised of publicly traded municipal bonds that cover the U.S. dollar denominated intermediate term tax-exempt bond market.

VanEck Intermediate Muni ETF

Click here to get full coverage on ITM Power (LON:ITM) Trading Up 18.4% - Still a Buy? - MarketBeat

ITM Power (LON:ITM) Trading Up 18.4% - Still a Buy?  MarketBeat

ITM Power (LON:ITM) Trading Up 18.4% - Still a Buy? - MarketBeat

Click here to get full coverage on (ITM) Investment Analysis - news.stocktradersdaily.com

(ITM) Investment Analysis  news.stocktradersdaily.com

(ITM) Investment Analysis - news.stocktradersdaily.com

Click here to get full coverage on ITM Power (LON:ITM) Trading 14.1% Higher - Here's What Happened - MarketBeat

ITM Power (LON:ITM) Trading 14.1% Higher - Here's What Happened  MarketBeat

ITM Power (LON:ITM) Trading 14.1% Higher - Here's What Happened - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading 18.4% Higher - Should You Buy? - MarketBeat

ITM Power (LON:ITM) Trading 18.4% Higher - Should You Buy?  MarketBeat

ITM Power (LON:ITM) Trading 18.4% Higher - Should You Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Shares Up 18.4% - Here's What Happened - MarketBeat

ITM Power (LON:ITM) Shares Up 18.4% - Here's What Happened  MarketBeat

ITM Power (LON:ITM) Shares Up 18.4% - Here's What Happened - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading 12.8% Higher - Here's Why - MarketBeat

ITM Power (LON:ITM) Trading 12.8% Higher - Here's Why  MarketBeat

ITM Power (LON:ITM) Trading 12.8% Higher - Here's Why - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading 14.2% Higher - Here's What Happened - MarketBeat

ITM Power (LON:ITM) Trading 14.2% Higher - Here's What Happened  MarketBeat

ITM Power (LON:ITM) Trading 14.2% Higher - Here's What Happened - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Shares Down 9.8% - Here's Why - MarketBeat

ITM Power (LON:ITM) Shares Down 9.8% - Here's Why  MarketBeat

ITM Power (LON:ITM) Shares Down 9.8% - Here's Why - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Shares Down 3.9% - Here's What Happened - MarketBeat

ITM Power (LON:ITM) Shares Down 3.9% - Here's What Happened  MarketBeat

ITM Power (LON:ITM) Shares Down 3.9% - Here's What Happened - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Shares Up 12.3% - What's Next? - MarketBeat

ITM Power (LON:ITM) Shares Up 12.3% - What's Next?  MarketBeat

ITM Power (LON:ITM) Shares Up 12.3% - What's Next? - MarketBeat

Click here to get full coverage on ITM Power (OTCMKTS:ITMPF) Stock Price Down 13.1% - Here's What Happened - MarketBeat

ITM Power (OTCMKTS:ITMPF) Stock Price Down 13.1% - Here's What Happened  MarketBeat

ITM Power (OTCMKTS:ITMPF) Stock Price Down 13.1% - Here's What Happened - MarketBeat

Click here to get full coverage on ITM Power (OTCMKTS:ITMPF) Reaches New 12-Month High - Time to Buy? - MarketBeat

ITM Power (OTCMKTS:ITMPF) Reaches New 12-Month High - Time to Buy?  MarketBeat

ITM Power (OTCMKTS:ITMPF) Reaches New 12-Month High - Time to Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Shares Up 11.9% - Here's Why - MarketBeat

ITM Power (LON:ITM) Shares Up 11.9% - Here's Why  MarketBeat

ITM Power (LON:ITM) Shares Up 11.9% - Here's Why - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading 22.7% Higher - Still a Buy? - MarketBeat

ITM Power (LON:ITM) Trading 22.7% Higher - Still a Buy?  MarketBeat

ITM Power (LON:ITM) Trading 22.7% Higher - Still a Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading Up 12.3% - Time to Buy? - MarketBeat

ITM Power (LON:ITM) Trading Up 12.3% - Time to Buy?  MarketBeat

ITM Power (LON:ITM) Trading Up 12.3% - Time to Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Stock Price Up 12.3% - Here's Why - MarketBeat

ITM Power (LON:ITM) Stock Price Up 12.3% - Here's Why  MarketBeat

ITM Power (LON:ITM) Stock Price Up 12.3% - Here's Why - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Shares Up 22.7% - Here's Why - MarketBeat

ITM Power (LON:ITM) Shares Up 22.7% - Here's Why  MarketBeat

ITM Power (LON:ITM) Shares Up 22.7% - Here's Why - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading Up 16.7% - Time to Buy? - MarketBeat

ITM Power (LON:ITM) Trading Up 16.7% - Time to Buy?  MarketBeat

ITM Power (LON:ITM) Trading Up 16.7% - Time to Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Stock Price Up 12.3% - Time to Buy? - MarketBeat

ITM Power (LON:ITM) Stock Price Up 12.3% - Time to Buy?  MarketBeat

ITM Power (LON:ITM) Stock Price Up 12.3% - Time to Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Shares Up 12.3% - Should You Buy? - MarketBeat

ITM Power (LON:ITM) Shares Up 12.3% - Should You Buy?  MarketBeat

ITM Power (LON:ITM) Shares Up 12.3% - Should You Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading 12.3% Higher - Here's What Happened - MarketBeat

ITM Power (LON:ITM) Trading 12.3% Higher - Here's What Happened  MarketBeat

ITM Power (LON:ITM) Trading 12.3% Higher - Here's What Happened - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading Up 14.1% - What's Next? - MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - What's Next?  MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - What's Next? - MarketBeat

Click here to get full coverage on ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds - GlobeNewswire

ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds  GlobeNewswire

ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds - GlobeNewswire

Click here to get full coverage on ITM forges $263M debt financing agreement - AuntMinnie

ITM forges $263M debt financing agreement  AuntMinnie

ITM forges $263M debt financing agreement - AuntMinnie

Click here to get full coverage on ITM Announces Positive Topline Results of Phase 3 COMPETE Trial with ITM-11, a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or Grade 2 Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - GlobeNewswire

ITM Announces Positive Topline Results of Phase 3 COMPETE Trial with ITM-11, a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or Grade 2 Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)  GlobeNewswire

ITM Announces Positive Topline Results of Phase 3 COMPETE Trial with ITM-11, a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or Grade 2 Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - GlobeNewswire

Click here to get full coverage on ITM Power Strengthens Management Stake with Share Incentive Plan - TipRanks

ITM Power Strengthens Management Stake with Share Incentive Plan  TipRanks

ITM Power Strengthens Management Stake with Share Incentive Plan - TipRanks

Click here to get full coverage on ITM, Radiopharm ink Lu-177 supply agreement - AuntMinnie

ITM, Radiopharm ink Lu-177 supply agreement  AuntMinnie

ITM, Radiopharm ink Lu-177 supply agreement - AuntMinnie

Click here to get full coverage on ITM Power (LON:ITM) Trading Up 14.1% - Time to Buy? - MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - Time to Buy?  MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - Time to Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading 14.1% Higher - Here's Why - MarketBeat

ITM Power (LON:ITM) Trading 14.1% Higher - Here's Why  MarketBeat

ITM Power (LON:ITM) Trading 14.1% Higher - Here's Why - MarketBeat

Click here to get full coverage on ITM shares details of radiopharma's phase 3 win, reveals overall survival miss - Fierce Biotech

ITM shares details of radiopharma's phase 3 win, reveals overall survival miss  Fierce Biotech

ITM shares details of radiopharma's phase 3 win, reveals overall survival miss - Fierce Biotech

Click here to get full coverage on ITM Power (LON:ITM) Trading Up 14.1% - Still a Buy? - MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - Still a Buy?  MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - Still a Buy? - MarketBeat

Click here to get full coverage on ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 - GlobeNewswire

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225  GlobeNewswire

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 - GlobeNewswire

Click here to get full coverage on ITM lands $262.5M debt deal to fund targeted radiotherapy in GEP-NETs - FirstWord Pharma

ITM lands $262.5M debt deal to fund targeted radiotherapy in GEP-NETs  FirstWord Pharma

ITM lands $262.5M debt deal to fund targeted radiotherapy in GEP-NETs - FirstWord Pharma

Click here to get full coverage on ITM targets US approval for radiopharmaceutical after Phase III readout - Pharmaceutical Technology

ITM targets US approval for radiopharmaceutical after Phase III readout  Pharmaceutical Technology

ITM targets US approval for radiopharmaceutical after Phase III readout - Pharmaceutical Technology

Click here to get full coverage on ITM Power (LON:ITM) Trading 14.1% Higher - Still a Buy? - MarketBeat

ITM Power (LON:ITM) Trading 14.1% Higher - Still a Buy?  MarketBeat

ITM Power (LON:ITM) Trading 14.1% Higher - Still a Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading Up 14.1% - Here's What Happened - MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - Here's What Happened  MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - Here's What Happened - MarketBeat

Click here to get full coverage on ITM fleshes out data for Phase III radiopharma success in neuroendocrine tumours - FirstWord Pharma

ITM fleshes out data for Phase III radiopharma success in neuroendocrine tumours  FirstWord Pharma

ITM fleshes out data for Phase III radiopharma success in neuroendocrine tumours - FirstWord Pharma

Click here to get full coverage on ITM Power (LON:ITM) Shares Up 14.1% - Time to Buy? - MarketBeat

ITM Power (LON:ITM) Shares Up 14.1% - Time to Buy?  MarketBeat

ITM Power (LON:ITM) Shares Up 14.1% - Time to Buy? - MarketBeat

Click here to get full coverage on ITM Appoints Dr. Celine Wilke as Chief Medical Officer - GlobeNewswire

ITM Appoints Dr. Celine Wilke as Chief Medical Officer  GlobeNewswire

ITM Appoints Dr. Celine Wilke as Chief Medical Officer - GlobeNewswire

Click here to get full coverage on ITM Power (LON:ITM) Shares Up 14.1% - Should You Buy? - MarketBeat

ITM Power (LON:ITM) Shares Up 14.1% - Should You Buy?  MarketBeat

ITM Power (LON:ITM) Shares Up 14.1% - Should You Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Trading Up 14.1% - Should You Buy? - MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - Should You Buy?  MarketBeat

ITM Power (LON:ITM) Trading Up 14.1% - Should You Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Stock Price Up 14.1% - Still a Buy? - MarketBeat

ITM Power (LON:ITM) Stock Price Up 14.1% - Still a Buy?  MarketBeat

ITM Power (LON:ITM) Stock Price Up 14.1% - Still a Buy? - MarketBeat

Click here to get full coverage on ITM Presents Positive Topline Phase 3 COMPETE Trial Data - GlobeNewswire

ITM Presents Positive Topline Phase 3 COMPETE Trial Data  GlobeNewswire

ITM Presents Positive Topline Phase 3 COMPETE Trial Data - GlobeNewswire

Click here to get full coverage on Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says - BioPharma Dive

Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says  BioPharma Dive

Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says - BioPharma Dive

Click here to get full coverage on ITM Power (LON:ITM) Trading 14.1% Higher - Time to Buy? - MarketBeat

ITM Power (LON:ITM) Trading 14.1% Higher - Time to Buy?  MarketBeat

ITM Power (LON:ITM) Trading 14.1% Higher - Time to Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Stock Price Up 14.1% - Should You Buy? - MarketBeat

ITM Power (LON:ITM) Stock Price Up 14.1% - Should You Buy?  MarketBeat

ITM Power (LON:ITM) Stock Price Up 14.1% - Should You Buy? - MarketBeat

Click here to get full coverage on ITM Power (LON:ITM) Shares Up 14.1% - What's Next? - MarketBeat

ITM Power (LON:ITM) Shares Up 14.1% - What's Next?  MarketBeat

ITM Power (LON:ITM) Shares Up 14.1% - What's Next? - MarketBeat

Click here to get full coverage on ITM Announces Updates to Commercial Leadership - GlobeNewswire

ITM Announces Updates to Commercial Leadership  GlobeNewswire

ITM Announces Updates to Commercial Leadership - GlobeNewswire

Click here to get full coverage on Barbara Weber, M.D., Elected to ITM Supervisory Board - GlobeNewswire

Barbara Weber, M.D., Elected to ITM Supervisory Board  GlobeNewswire

Barbara Weber, M.D., Elected to ITM Supervisory Board - GlobeNewswire

Click here to get full coverage on ITM Power (LON:ITM) Stock Price Up 14.1% - Here's Why - MarketBeat

ITM Power (LON:ITM) Stock Price Up 14.1% - Here's Why  MarketBeat

ITM Power (LON:ITM) Stock Price Up 14.1% - Here's Why - MarketBeat

Click here to get full coverage on ITM-11 succeeds in phase 3: The first big win for radiopharma? - Labiotech.eu

ITM-11 succeeds in phase 3: The first big win for radiopharma?  Labiotech.eu

ITM-11 succeeds in phase 3: The first big win for radiopharma? - Labiotech.eu

Click here to get full coverage on NAVAC Taps ITM Instruments as its Canadian Repair Shop - ACHR News

NAVAC Taps ITM Instruments as its Canadian Repair Shop  ACHR News

NAVAC Taps ITM Instruments as its Canadian Repair Shop - ACHR News

Click here to get full coverage on ITM’s radiotherapeutic beats out standard-of-care in Phase III trial - Clinical Trials Arena

ITM’s radiotherapeutic beats out standard-of-care in Phase III trial  Clinical Trials Arena

ITM’s radiotherapeutic beats out standard-of-care in Phase III trial - Clinical Trials Arena

Click here to get full coverage on ITM Power Have Signed a Contract to Supply a NEPTUNE II Unit to a Spanish Cement Producer - Fuel Cells Works

ITM Power Have Signed a Contract to Supply a NEPTUNE II Unit to a Spanish Cement Producer  Fuel Cells Works

ITM Power Have Signed a Contract to Supply a NEPTUNE II Unit to a Spanish Cement Producer - Fuel Cells Works

Click here to get full coverage on ITM-11 boosts survival in neuroendocrine tumour trial - Drug Target Review

ITM-11 boosts survival in neuroendocrine tumour trial  Drug Target Review

ITM-11 boosts survival in neuroendocrine tumour trial - Drug Target Review

Click here to get full coverage on Germany’s ITM, a stalwart in radiopharmaceuticals, gets ready to take its own shots - statnews.com

Germany’s ITM, a stalwart in radiopharmaceuticals, gets ready to take its own shots  statnews.com

Germany’s ITM, a stalwart in radiopharmaceuticals, gets ready to take its own shots - statnews.com

Click here to get full coverage on ITM Power (LON:ITM) Stock Price Up 14.1% - Here's What Happened - MarketBeat

ITM Power (LON:ITM) Stock Price Up 14.1% - Here's What Happened  MarketBeat

ITM Power (LON:ITM) Stock Price Up 14.1% - Here's What Happened - MarketBeat

Click here to get full coverage on ITM Institute of Design & Media Launches 4-Week Pre-Foundation Bootcamp for Aspiring Designers - SMEStreet

ITM Institute of Design & Media Launches 4-Week Pre-Foundation Bootcamp for Aspiring Designers  SMEStreet

ITM Institute of Design & Media Launches 4-Week Pre-Foundation Bootcamp for Aspiring Designers - SMEStreet

Click here to get full coverage on ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Yahoo Finance

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177  Yahoo Finance

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Yahoo Finance

Click here to get full coverage on ITM reports more Phase 3 radiopharma data in challenge to Novartis’ Lutathera - Endpoints News

ITM reports more Phase 3 radiopharma data in challenge to Novartis’ Lutathera  Endpoints News

ITM reports more Phase 3 radiopharma data in challenge to Novartis’ Lutathera - Endpoints News

Click here to get full coverage on ITM Power Secures 300MW Electrolyser Contract for Major Green Hydrogen Project in Asia-Pacific - Fuel Cells Works

ITM Power Secures 300MW Electrolyser Contract for Major Green Hydrogen Project in Asia-Pacific  Fuel Cells Works

ITM Power Secures 300MW Electrolyser Contract for Major Green Hydrogen Project in Asia-Pacific - Fuel Cells Works

Click here to get full coverage on ITM Power (LON:ITM) Shares Up 14.1% - Here's What Happened - MarketBeat

ITM Power (LON:ITM) Shares Up 14.1% - Here's What Happened  MarketBeat

ITM Power (LON:ITM) Shares Up 14.1% - Here's What Happened - MarketBeat

Click here to get full coverage on Optometry Students at ITM Institute of Health Sciences Gain Hands-On Training with Shamir Lens Workshop - APN News

Optometry Students at ITM Institute of Health Sciences Gain Hands-On Training with Shamir Lens Workshop  APN News

Optometry Students at ITM Institute of Health Sciences Gain Hands-On Training with Shamir Lens Workshop - APN News

Click here to get full coverage on ITM Power (LON:ITM) Trading 14.1% Higher - What's Next? - MarketBeat

ITM Power (LON:ITM) Trading 14.1% Higher - What's Next?  MarketBeat

VanEck Intermediate Muni ETF (ITM)

Price Chart

Key Statistics

Top 10 Holdings Distribution

Technicals

About ITM

Latest News

ITM Power (LON:ITM) Trading Up 18.4% - Still a Buy? - MarketBeat

(ITM) Investment Analysis - news.stocktradersdaily.com

ITM Power (LON:ITM) Trading 14.1% Higher - Here's What Happened - MarketBeat

Advanced Charts

Fund Information